The Tn antigen is a well-known tumor-associated carbohydrate determinant, often incorporated in glycopeptides to develop cancer vaccines. Herein, four copies of a conformationally constrained mimetic of the antigen TnThr (GalNAc-Thr) were conjugated to the adjuvant CRM197, a protein licensed for human use. The resulting vaccine candidate, mime[4]CRM elicited a robust immune response in a triple-negative breast cancer mouse model, correlated with high frequency of CD4+ T cells and low frequency of M2-type macrophages, which reduces tumor progression and lung metastasis growth. Mime[4]CRM-mediated activation of human dendritic cells is reported, and the proliferation of mime[4]CRM-specific T cells, in cancer tissue and peripheral blood of patients with breast cancer, is demonstrated. The locked conformation of the TnThr mimetic and a proper presentation on the surface of CRM197 may explain the binding of the conjugate to the anti-Tn antibody Tn218 and its efficacy to fight cancer cells in mice.

A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer / A. Amedei, F. Asadzadeh, F. Papi, M.G. Vannucchi, V. Ferrucci, I.A. Bermejo, M. Fragai, C.V. De Almeida, L. Cerofolini, S. Giuntini, M. Bombaci, E. Pesce, E. Niccolai, F. Natali, E. Guarini, F. Gabel, C. Traini, S. Catarinicchia, F. Ricci, L. Orzalesi, F. Berti, F. Corzana, M. Zollo, R. Grifantini, C. Nativi. - In: ISCIENCE. - ISSN 2589-0042. - 23:6(2020 Jun 26), pp. 101250.1-101250.53. [10.1016/j.isci.2020.101250]

A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer

E. Pesce;
2020

Abstract

The Tn antigen is a well-known tumor-associated carbohydrate determinant, often incorporated in glycopeptides to develop cancer vaccines. Herein, four copies of a conformationally constrained mimetic of the antigen TnThr (GalNAc-Thr) were conjugated to the adjuvant CRM197, a protein licensed for human use. The resulting vaccine candidate, mime[4]CRM elicited a robust immune response in a triple-negative breast cancer mouse model, correlated with high frequency of CD4+ T cells and low frequency of M2-type macrophages, which reduces tumor progression and lung metastasis growth. Mime[4]CRM-mediated activation of human dendritic cells is reported, and the proliferation of mime[4]CRM-specific T cells, in cancer tissue and peripheral blood of patients with breast cancer, is demonstrated. The locked conformation of the TnThr mimetic and a proper presentation on the surface of CRM197 may explain the binding of the conjugate to the anti-Tn antibody Tn218 and its efficacy to fight cancer cells in mice.
Cancer; Immunology; Medical Biochemistry
Settore CHIM/06 - Chimica Organica
Settore MED/04 - Patologia Generale
Settore CHEM-05/A - Chimica organica
Settore MEDS-02/A - Patologia generale
26-giu-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2589004220304363-main.pdf

accesso aperto

Descrizione: Article
Tipologia: Publisher's version/PDF
Dimensione 11.96 MB
Formato Adobe PDF
11.96 MB Adobe PDF Visualizza/Apri
1-s2.0-S2589004220304363-main_compressed.pdf

accesso aperto

Descrizione: file compresso
Tipologia: Publisher's version/PDF
Dimensione 2.55 MB
Formato Adobe PDF
2.55 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1097148
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact